LogicBio Therapeutics Inc (OQ:LOGC)

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for LOGC within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET January 25th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Dec 23/19 Dec 19/19 Kay Mark A Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 10,869  
Dec 20/19 Dec 19/19 O'Connell Daniel P Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 10,869  
Dec 20/19 Dec 19/19 Moscicki Richard A Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 10,869  
Dec 20/19 Dec 19/19 Wyzga Michael S Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 10,869  
Dec 20/19 Dec 19/19 Chen Leon Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 10,869  
Dec 20/19 Dec 19/19 Chimovits Erez Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 10,869  
Dec 20/19 Dec 19/19 Kariv Tomer Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 10,869  
Dec 13/19 Dec 11/19 Yoon Seokho Bryan Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 110,000  
Aug 29/19 Aug 27/19 Wilton Thomas Direct Ownership Employee Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 75,000  
Aug 29/19 Aug 27/19 Wilton Thomas Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 75,000 $0.730
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for LOGC within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET January 25th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Dec 23/19 Dec 19/19 Kay Mark A Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 10,869  
Dec 20/19 Dec 19/19 O'Connell Daniel P Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 10,869  
Dec 20/19 Dec 19/19 Moscicki Richard A Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 10,869  
Dec 20/19 Dec 19/19 Wyzga Michael S Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 10,869  
Dec 20/19 Dec 19/19 Chen Leon Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 10,869  
Dec 20/19 Dec 19/19 Chimovits Erez Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 10,869  
Dec 20/19 Dec 19/19 Kariv Tomer Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 10,869  
Dec 13/19 Dec 11/19 Yoon Seokho Bryan Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 110,000  
Aug 29/19 Aug 27/19 Wilton Thomas Direct Ownership Employee Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 75,000  
Aug 29/19 Aug 27/19 Wilton Thomas Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 75,000 $0.730
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $LOGC

Competitors

Competitors with Recent Insider Filings
Horizon Therapeutics PLC (OQ:HZNP)
Arvinas (OQ:ARVN)
Merck & Co. (N:MRK)